WTF Are You Waiting ForJust another Site 1 Sites site

Like the mute button on the TV remote control, our brains filter out unwanted noise so we can focus on what we’re listening to. But when it comes to following our own speech, a new brain study from the University of California, Berkeley, shows that instead of one homogenous mute button, we have a network of volume settings that can selectively silence and amplify the sounds we make and hear…

Original post: Our Brains Are Wired So We Can Better Hear Ourselves Speak, New Study Shows

If you know what this is and where it’s located, you could win a prize in the CNET Road Trip Picture of the Week challenge.

Original post: Road Trip Pic of the Week, 1/13: What is this?

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application (BLA) for KRYSTEXXAâ„ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy…

Original post: Savient Announces KRYSTEXXA(TM) Resubmitted BLA Accepted For Review By The FDA

The massively popular, user-created encyclopedia hits a decade tomorrow, having thrived despite a series of controversies. Now, with data suggesting its growth has plateaued, how will the project evolve over the next 10 years?

Original post: At 10, highlighting Wikipedia’s past and future

A newly-published clinical study demonstrates that Colcrys® (colchicine, USP), a low-dose oral colchicine, is just as effective as high-dose colchicine in reducing pain associated with early acute gout flare, but with a safety profile statistically indistinguishable from placebo. The study, “High vs…

Original post: COLCRYS(R) (Colchicine, USP) Shows Superior Safety With Comparable Efficacy Compared To High-Dose Colchicine In Treatment Of Early Acute Gout Flares

Singapore’s airport offers a good look at the super-jumbo Airbus A380. You can also check out an unofficial Apple store, try out Microsoft’s Kinect, and watch koi swim. What a way to spend 18 hours.

Original post: In Singapore, even airplanes can have paparazzi

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010…

Original post: Nuon Therapeutics Identifies Novel Use And Advances NU1618 Into Development For Chronic Hyperuricemia In Patients With Gout

A standard called IndexedDB, useful for storing lots of data on a computer for tasks such as Web apps that work offline, is getting closer to being useful for Web developers.

Original post: Firefox beta getting new database standard

April 29, 2010. EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome…

Original post: EnzymeRx Announces Strong Phase 1 Results For Pegsitacase

A satirical Microsoft blog post asserts that H.264 is the lingua franca of digital video and that Google is foolish–at best–for trying to convince the world to move to WebM instead.

Original post: Microsoft mocks Google’s Web video decision